Incyte rides wave after Pfizer’s FDA panel nod

Pfizer ($PFE) scored the endorsement of an FDA panel for its arthritis pill tofacitinib this week, and the win could put some wind in the sails of drug developer Incyte ($INCY). Incyte's shares jumped…
Read the full story: News